机构:[1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120 PR China[2]Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405 PR China深圳市中医院深圳医学信息中心[3]Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510006 PR China广东省中医院[4]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau SAR, China
Influenza viruses pose a severe threat to human health and a significant increase in antiviral drug-resistant among influenza viruses worldwide has been observed. Therefore, there is an urgent need to develop the new antiviral drugs, specifically from the natural products. In this study, the anti-viral and anti-inflammatory activities of coumarins against influenza A virus in vitro were investigated. One of the derivatives eleutheroside B-1 showed a wide spectrum of anti-human influenza virus effect with the IC50 value of 64-125 mu g/ml in vitro, but it showed no effects against avian influenza virus. The time of addition was done and the results indicated that it had a potent antiviral effect when added at 0-6 h, and also the virus yield was reduced by 60%. The influenza virus ribonucleoprotein was inhibited at 200 mu g/ml, and also the NP mRNA expression was inhibited at 50 and 200 mu g/ml. The expression level of cytokines and chemokines influenced by eleutheroside B-1 was further demonstrated, the IL-6, CXCL-8, CCL-2 expression were all inhibited by the eleuthe roside B-1 at concentration 200 mu g/ml. The findings of study suggest that eleutheroside B-1 can be as potential agent to develop for the prevention and treatment of influenza A virus. (C) 2016 Elsevier Masson SAS. All rights reserved.
基金:
Engineering Technology Research Center (development) of Guangdong General Universities (No. GCZX-A1408), the Innovation Academic Team of Guangzhou Education System (No. 13C07), Guangzhou Municipal Science and Technology Program-Technology Benefiting Special (No. 2014Y2-00031), Collaborative Innovation major projects of Guangzhou Health Care (No.201400000002), International S&T Coorperation Program of Guangdong Province (No. 2013B051000085), Traditional Chinese Medicine of Guangdong Province (No. 20111208). The Special Science fund for Traditional Chinese Medicine (YN2014ZHR207), Guangdong Provincial Hospi-tal of Chinese Medicine.
基金编号:development
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类|3 区医学
小类|4 区医学:研究与实验4 区药学
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
JCR分区:
出版当年[2015]版:
Q3MEDICINE, RESEARCH & EXPERIMENTALQ3PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120 PR China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120 PR China[3]Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510006 PR China[4]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau SAR, China[*1]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, PR China.[*2]Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China.[*3]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau SAR, China.
推荐引用方式(GB/T 7714):
Wang YuTao,Yan Wen,Chen QiaoLian,et al.Inhibition viral RNP and anti-inflammatory activity of coumarins against influenza virus[J].BIOMEDICINE & PHARMACOTHERAPY.2017,87:583-588.doi:10.1016/j.biopha.2016.12.117.
APA:
Wang, YuTao,Yan, Wen,Chen, QiaoLian,Huang, WanYi,Yang, Zifeng...&Wang, XinHua.(2017).Inhibition viral RNP and anti-inflammatory activity of coumarins against influenza virus.BIOMEDICINE & PHARMACOTHERAPY,87,
MLA:
Wang, YuTao,et al."Inhibition viral RNP and anti-inflammatory activity of coumarins against influenza virus".BIOMEDICINE & PHARMACOTHERAPY 87.(2017):583-588